Searching the RRID Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Preparing word cloud

×

Suggested Search Criteria

Enter extra filters to help narrow your search

Search

Type in a keyword to search

Filter by records added date
See new records

Options


Current Facets and Filters

  • Mentions:yes (facet)

Facets


Recent searches

Snippet view Table view
Click the to add this resource to an Authentication Report or Collection

10,882 Results - per page

Show More Columns | Download Top 1000 Results

Name Proper Citation Organism Disease Comments Defining Citation Category Sex Synonyms Vendor Catalog Number Cross References Hierarchy Originate from Same Individual ID Record Last Update Mentions Count
NE-4C
 
Resource Report
Resource Website
10+ mentions
CLS Cat# 305182, RRID:CVCL_B063 Mus musculus (Mouse) PMID:9057134
PMID:16183159
Spontaneously immortalized cell line Sex unspecified CLS 305182 BTO:BTO_0005624,
ATCC:CRL-2925,
CCRID:3101MOUSCSP1501,
CLS:305182,
Wikidata:Q54930366
CVCL_B063 2026-09-05 11:41:01 12
NE-4C
 
Resource Report
Resource Website
10+ mentions
ATCC Cat# CRL-2925, RRID:CVCL_B063 Mus musculus (Mouse) PMID:9057134
PMID:16183159
Spontaneously immortalized cell line Sex unspecified ATCC CRL-2925 BTO:BTO_0005624,
ATCC:CRL-2925,
CCRID:3101MOUSCSP1501,
CLS:305182,
Wikidata:Q54930366
CVCL_B063 2026-09-05 11:41:01 12
OKT 3
 
Resource Report
Resource Website
1+ mentions
CLS Cat# 300499, RRID:CVCL_2665 Mus musculus (Mouse) Anecdotal: OKT3 was the first monoclonal antibody to be approved for clinical use in humans., Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized teplizumab (MGA031) therapeutic antibody., Biotechnology: The monoclonal antibody produced by this hybridoma was used as an immunosuppressant drug under the name Muromonab-CD3 (Orthoclone OKT3)., Group: Patented cell line. PMID:314668 Hybridoma OKT3 CLS 300499 CLO:CLO_0008252,
CLDB:cl5239,
ABCD:ABCD_AC852,
ATCC:CRL-8001,
BCRC:60154,
CCRID:3101ETCHYB58,
CLS:300499,
ECACC:86022706,
IZSLER:BS Hy 12,
NCBI_Iran:H104,
TKG:TKG 0235,
Wikidata:Q54931950
cvcl_3412 CVCL_2665 2026-09-05 11:41:03 4
OKT 3
 
Resource Report
Resource Website
1+ mentions
BCRC Cat# 60154, RRID:CVCL_2665 Mus musculus (Mouse) Anecdotal: OKT3 was the first monoclonal antibody to be approved for clinical use in humans., Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized teplizumab (MGA031) therapeutic antibody., Biotechnology: The monoclonal antibody produced by this hybridoma was used as an immunosuppressant drug under the name Muromonab-CD3 (Orthoclone OKT3)., Group: Patented cell line. PMID:314668 Hybridoma OKT3 BCRC 60154 CLO:CLO_0008252,
CLDB:cl5239,
ABCD:ABCD_AC852,
ATCC:CRL-8001,
BCRC:60154,
CCRID:3101ETCHYB58,
CLS:300499,
ECACC:86022706,
IZSLER:BS Hy 12,
NCBI_Iran:H104,
TKG:TKG 0235,
Wikidata:Q54931950
cvcl_3412 CVCL_2665 2026-09-05 11:41:03 4
OKT 3
 
Resource Report
Resource Website
1+ mentions
IZSLER Cat# BS Hy 12, RRID:CVCL_2665 Mus musculus (Mouse) Anecdotal: OKT3 was the first monoclonal antibody to be approved for clinical use in humans., Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized teplizumab (MGA031) therapeutic antibody., Biotechnology: The monoclonal antibody produced by this hybridoma was used as an immunosuppressant drug under the name Muromonab-CD3 (Orthoclone OKT3)., Group: Patented cell line. PMID:314668 Hybridoma OKT3 IZSLER BS Hy 12 CLO:CLO_0008252,
CLDB:cl5239,
ABCD:ABCD_AC852,
ATCC:CRL-8001,
BCRC:60154,
CCRID:3101ETCHYB58,
CLS:300499,
ECACC:86022706,
IZSLER:BS Hy 12,
NCBI_Iran:H104,
TKG:TKG 0235,
Wikidata:Q54931950
cvcl_3412 CVCL_2665 2026-09-05 11:41:03 4
OKT 3
 
Resource Report
Resource Website
1+ mentions
ATCC Cat# CRL-8001, RRID:CVCL_2665 Mus musculus (Mouse) Anecdotal: OKT3 was the first monoclonal antibody to be approved for clinical use in humans., Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized teplizumab (MGA031) therapeutic antibody., Biotechnology: The monoclonal antibody produced by this hybridoma was used as an immunosuppressant drug under the name Muromonab-CD3 (Orthoclone OKT3)., Group: Patented cell line. PMID:314668 Hybridoma OKT3 ATCC CRL-8001 CLO:CLO_0008252,
CLDB:cl5239,
ABCD:ABCD_AC852,
ATCC:CRL-8001,
BCRC:60154,
CCRID:3101ETCHYB58,
CLS:300499,
ECACC:86022706,
IZSLER:BS Hy 12,
NCBI_Iran:H104,
TKG:TKG 0235,
Wikidata:Q54931950
cvcl_3412 CVCL_2665 2026-09-05 11:41:03 4
OAT1 HEK 293T/17
 
Resource Report
Resource Website
1+ mentions
ATCC Cat# CRL-11268G-1, RRID:CVCL_UE07 Homo sapiens (Human) Transformed cell line Female OAT1-HEK ATCC CRL-11268G-1 ATCC:CRL-11268G-1,
Wikidata:Q98128276
cvcl_1926 CVCL_UE07 2026-09-05 11:41:02 7
NIH 3T3 Met-WT
 
Resource Report
Resource Website
1+ mentions
Kerafast Cat# ENH023-FP, RRID:CVCL_ZD67 Mus musculus (Mouse) PMID:9326629
PMID:10327054
Spontaneously immortalized cell line Male Murine MET (Wild-Type) Expressing NIH3T3 Cell Line Kerafast ENH023-FP Kerafast:ENH023-FP,
Wikidata:Q98127854
cvcl_0594 CVCL_ZD67 2026-09-05 11:41:02 1
NHBEC BMI-1 6
 
Resource Report
Resource Website
1+ mentions
Ximbio Cat# 153586, RRID:CVCL_VP25 Homo sapiens (Human) Characteristics: Has an extended lifespan compared to primary bronchial epithelial cells. Retains both viability and differentiation potential of wild-type human bronchial epithelium. Finite cell line Male BMI-1 6 Ximbio 153586 CancerTools:153586,
Wikidata:Q98127770,
Ximbio:153586
CVCL_VP25 2026-09-05 11:41:01 1
NK-92MI
 
Resource Report
Resource Website
10+ mentions
Discontinued
Possibly Discontinued
BCRC Cat# 60438, RRID:CVCL_3755 Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma Caution: This cell line is exclusively owned and controlled by NantKwest, Inc. NantKwest and its affiliate, Brink Biologics, Inc. are the sole authorized distributors for both commercial and non-commercial research requestors. There are no other authorized commercial and non-commercial suppliers of NK-92MI. Contact NantKwest and Brink Biologics for information concerning current inventory and cell line use and support., Characteristics: No longer dependent on IL2., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line. PMID:10365666
PMID:27397505
PMID:30894373
PMID:35839778
Cancer cell line Male NK-92 MI, NK-92 mi, NK92-MI, NK92MI, NK-92 transfected with MFG-hIL2 BCRC 60438 CLO:CLO_0008178,
ATCC:CRL-2408,
BCRC:60438,
cancercelllines:CVCL_3755,
CCRID:1102HUM-NIFDC00065,
Cell_Model_Passport:SIDM01201,
Cosmic-CLP:1330981,
DepMap:ACH-002289,
GDSC:1330981,
GEO:GSM1670278,
KCB:KCB 200677YJ,
LINCS_LDP:LCL-1127,
PharmacoDB:NK92MI_1160_2019,
PRIDE:PXD030304,
Wikidata:Q54930658
cvcl_2142 CVCL_3755 2026-09-05 11:41:02 24
NoGFP-CD16.NK92
 
Resource Report
Resource Website
1+ mentions
ATCC Cat# PTA-6967, RRID:CVCL_V429 Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma Population: Caucasian., Group: Patented cell line. Cancer cell line Male ATCC PTA-6967 ATCC:PTA-6967,
Wikidata:Q54930889
cvcl_2142 CVCL_V429 2026-09-05 11:41:02 6
OKT 3
 
Resource Report
Resource Website
1+ mentions
NCBI_Iran Cat# H104, RRID:CVCL_2665 Mus musculus (Mouse) Anecdotal: OKT3 was the first monoclonal antibody to be approved for clinical use in humans., Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized teplizumab (MGA031) therapeutic antibody., Biotechnology: The monoclonal antibody produced by this hybridoma was used as an immunosuppressant drug under the name Muromonab-CD3 (Orthoclone OKT3)., Group: Patented cell line. PMID:314668 Hybridoma OKT3 NCBI_Iran H104 CLO:CLO_0008252,
CLDB:cl5239,
ABCD:ABCD_AC852,
ATCC:CRL-8001,
BCRC:60154,
CCRID:3101ETCHYB58,
CLS:300499,
ECACC:86022706,
IZSLER:BS Hy 12,
NCBI_Iran:H104,
TKG:TKG 0235,
Wikidata:Q54931950
cvcl_3412 CVCL_2665 2026-09-05 11:41:03 4
NK-92MI
 
Resource Report
Resource Website
10+ mentions
Possibly Discontinued
Discontinued
ATCC Cat# CRL-2408, RRID:CVCL_3755 Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma Caution: This cell line is exclusively owned and controlled by NantKwest, Inc. NantKwest and its affiliate, Brink Biologics, Inc. are the sole authorized distributors for both commercial and non-commercial research requestors. There are no other authorized commercial and non-commercial suppliers of NK-92MI. Contact NantKwest and Brink Biologics for information concerning current inventory and cell line use and support., Characteristics: No longer dependent on IL2., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line. PMID:10365666
PMID:27397505
PMID:30894373
PMID:35839778
Cancer cell line Male NK-92 MI, NK-92 mi, NK92-MI, NK92MI, NK-92 transfected with MFG-hIL2 ATCC CRL-2408 CLO:CLO_0008178,
ATCC:CRL-2408,
BCRC:60438,
cancercelllines:CVCL_3755,
CCRID:1102HUM-NIFDC00065,
Cell_Model_Passport:SIDM01201,
Cosmic-CLP:1330981,
DepMap:ACH-002289,
GDSC:1330981,
GEO:GSM1670278,
KCB:KCB 200677YJ,
LINCS_LDP:LCL-1127,
PharmacoDB:NK92MI_1160_2019,
PRIDE:PXD030304,
Wikidata:Q54930658
cvcl_2142 CVCL_3755 2026-09-05 11:41:02 24
NuLi-1
 
Resource Report
Resource Website
1+ mentions
ATCC Cat# CRL-4011, RRID:CVCL_C455 Homo sapiens (Human) PMID:12676769
PMID:17191107
Transformed cell line Male NuLi1, Normal Lung, University of Iowa-1 ATCC CRL-4011 ATCC:CRL-4011,
BioSample:SAMN03471719,
CancerTools:154444,
Wikidata:Q54931171
CVCL_C455 2026-09-05 11:41:02 2
OKT 4
 
Resource Report
Resource Website
1+ mentions
NCBI_Iran Cat# H101, RRID:CVCL_2666 Mus musculus (Mouse) Group: Patented cell line. PMID:314668 Hybridoma OKT4, OKT-4 NCBI_Iran H101 CLO:CLO_0008253,
CLDB:cl5240,
ABCD:ABCD_AN714,
ATCC:CRL-8002,
BCRC:60235,
ECACC:87012602,
IZSLER:BS Hy 13,
KCLB:28002,
NCBI_Iran:H101,
TKG:TKG 0236,
Wikidata:Q54931951
cvcl_3412 CVCL_2666 2026-09-05 11:41:03 1
OP9/G-DLL1
 
Resource Report
Resource Website
1+ mentions
Discontinued
Millipore Cat# SCC136, RRID:CVCL_B218 Mus musculus (Mouse) Characteristics: Transduced with a retroviral construct Dll1-IRES-eGFP thereby allowing bicistronic expression of Dll1 and eGFP (Millipore=SCC136)., Characteristics: Does not produce Csf1 (M-CSF) due to a mutation in the gene. PMID:20810995 Stromal cell line Sex unspecified OP9-DL1 Millipore SCC136 CLO:CLO_0050191,
GEO:GSM562064,
Millipore:SCC136,
RCB:RCB2122,
RCB:RCB2925,
Wikidata:Q54936444
cvcl_4398 CVCL_B218 2026-09-05 11:41:03 6
OS3 [Mouse brain]
 
Resource Report
Resource Website
1+ mentions
RCB Cat# RCB1593, RRID:CVCL_U177 Mus musculus (Mouse) PMID:1335367
PMID:7783968
Transformed cell line RCB RCB1593 CLO:CLO_0050904,
RCB:RCB1593,
Wikidata:Q54936560
CVCL_U177 2026-09-05 11:41:03 1
OKT 9
 
Resource Report
Resource Website
1+ mentions
ATCC Cat# CRL-8021, RRID:CVCL_2670 Mus musculus (Mouse) Group: Patented cell line. Hybridoma OKT9, SFX.1 ATCC CRL-8021 CLO:CLO_0008258,
ATCC:CRL-8021,
ECACC:86022707,
NCBI_Iran:H125,
TKG:TKG 0238,
Wikidata:Q54931955
cvcl_3412 CVCL_2670 2026-09-05 11:41:03 2
OP9/N-DLL1
 
Resource Report
Resource Website
1+ mentions
Discontinued
RCB Cat# RCB2124, RRID:CVCL_B220 Mus musculus (Mouse) Stromal cell line Sex unspecified RCB RCB2124 CLO:CLO_0050188,
RCB:RCB2124,
RCB:RCB2927,
Wikidata:Q54936446
cvcl_b219 CVCL_B220 2026-09-05 11:41:03 2
OX-22
 
Resource Report
Resource Website
1+ mentions
ECACC Cat# 84112013, RRID:CVCL_G685 Mus musculus (Mouse) Hybridoma OX22 ECACC 84112013 ECACC:84112013,
Wikidata:Q54937085
cvcl_2155 CVCL_G685 2026-09-05 11:41:04 1

Can't find your Cell Line?

We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific cell line, it's easier to enter an RRID or add the vendor information to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.

If you still could not find your cell line in the search results, please help us by registering it into the system — it's easy. Register it with the Cellosaurus. An RRID will be generated in 1-2 business days.

Can't find the RRID you're searching for? X
X
  1. RRID Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  6. Facets

    Here are the facets that you can filter the data by.

  7. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.